Previous Page  4 / 23 Next Page
Information
Show Menu
Previous Page 4 / 23 Next Page
Page Background

Pharmacognosy 2019

March 11-12, 2019

London, UK

American Journal of Ethnomedicine

ISSN: 2348-9502

Page 40

Pharmacognosy and

Medicinal Plants

7

th

Edition of International Conference on

Nenad Stojiljković et al., Am J Ethnomed 2019, Volume 6

DOI: 10.21767/2348-9502-C1-009

Nanoliposome encapsulated lycopene ameliorates

methotrexate-induced hepatotoxicity

Nenad Stojiljković, Sonja Ilić, Nikola Stojanović, Milan Stoiljković

and

Slavica Stojnev

University of Nis, Serbia

Introduction:

Nano liposomes have the potential

to increase bioavailability, stability, improve time-

controlled drug releasing, enable cell specific

targeting and decrease adverse effects of drugs. In

this study, we evaluated the potential protective effect

of lycopene, a potent antioxidant carotenoid, given in

free and encapsulated form in methotrexate induced

hepatotoxicity in rats.

Methods:

Experiments were performed on 48 male

Wistar rats divided into eight groups of 6 animals,

treated daily by an intraperitoneal injection. MTX group

received methotrexate in a single dose (20 mg/kg) on

the first day; other experimental groups received the

same dose of methotrexate and empty nanoliposomes

(10 mL/kg) (MTX-NL-group), lycopene (6 mg/kg)

(MTX-LYC-group) and encapsulated lycopene (6 mg/

kg) (MTX-ENL-group), for 10 days. The remaining four

groups served as controls and received for 10 days:

corn oil (0.2 mL/day) (C-group), empty nanoliposomes

(10 mL/kg) (NL-group), lycopene (6 mg/kg) (LYC-group)

and encapsulated lycopene (6 mg/kg) (ENL-group).

Quantitative evaluation of structural and functional

changes of liver was performed by histopathological

(HE staining) and biochemical serum analyses and

determination of oxidative stress parameters.

Results:

Methotrexate induced severe functional and

morphological alterations of liver with conspicuous

disorganization of hepatic cords. Hepatocytes diffusely

exhibited apoptosis and degeneration with vacuolation

of the cytoplasm. Portal veins and sinusoid capillaries

showed congestion. Marked inflammatory infiltratewas

present in the portal tract (Figure 1E). Pathohistological

findings were followed by AST and ALT increase and

disturbances of tissue antioxidant status. Application

of both forms of lycopene ameliorated changes in

serum AST and ALT and oxidative damage markers

and markedly reversed structural changes of liver

tissue induced by methotrexate. Animals that received

nanoliposome encapsulated lycopene showed higher

degree of recovery then those treated with free

lycopene in Figure 1.

Discussion:

Encapsulated lycopene was shown to

possess stronger antioxidant activity which could be

possibly related to its position in the lipid bilayer and its

higher stability in nanoliposomes which might prolong

the presence of lycopene in circulation. Treatment with

nanoliposome-encapsulated lycopene compared to free

lycopene has an advantage since it has more efficiently

reduced methotrexate induced hepatotoxicity.

Figure 1: Histological evaluation of liver tissue (HE, 400x) in: (A) C-group;

(B) NL-group; (C) LYC group; (D) ENL group; (E) MTX group; (F) MTX-NL

group; (G) MTX-LYC group and (H) MTX-ENL group